Mertk Reduces Blood-Spinal Cord Barrier Permeability Through the Rhoa/Rock1/P-MLC Pathway After Spinal Cord Injury

Area of Science:

• Neuroscience
• Cell Biology
• Regenerative Medicine

Background:

• Disruption of the blood-spinal cord barrier (BSCB) exacerbates secondary injury after spinal cord injury (SCI).
• The precise role of Mertk in BSCB integrity and repair following SCI is not well understood.
• Mertk is known to influence inflammatory responses and cytoskeletal organization.

Purpose of the Study:

• To elucidate the specific function of Mertk in the repair of the BSCB after SCI.
• To investigate the molecular mechanisms by which Mertk influences BSCB permeability and subsequent outcomes.
• To evaluate the therapeutic potential of targeting Mertk for SCI recovery.

Main Methods:

• Quantification of Mertk expression in endothelial cells post-SCI.
• Overexpression of Mertk in SCI models.
• Assessment of BSCB permeability and tight junction protein expression.
• Evaluation of inflammatory markers and apoptosis.
• Analysis of neural regeneration and functional recovery.
• Investigation of the RhoA/Rock1/P-MLC signaling pathway.

Main Results:

• Mertk expression was significantly decreased in endothelial cells following SCI.
• Overexpression of Mertk led to the upregulation of tight junction proteins, decreasing BSCB permeability.
• Reduced BSCB permeability correlated with inhibited inflammation and apoptosis.
• Mertk-mediated effects were linked to the RhoA/Rock1/P-MLC pathway.
• Enhanced neural regeneration and functional recovery were observed in Mertk-overexpressing models.

Conclusions:

• Mertk plays a critical role in the repair of the BSCB following SCI.
• Targeting Mertk can mitigate BSCB disruption, reduce secondary injury, and promote functional recovery.
• The RhoA/Rock1/P-MLC pathway is a key mediator of Mertk's beneficial effects in SCI.
• Mertk represents a promising therapeutic target for spinal cord injury repair.